Targeting multiple opioid receptors – improved analgesics with reduced side effects? von Günther, Thomas, Dasgupta, Pooja, Mann, Anika, Miess, Elke, Kliewer, Andrea, Fritzwanker, Sebastian, Steinborn, Ralph, Schulz, Stefan

Volltext

Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists von Gillis, A, Gondin, AB, Kliewer, A, Sanchez, J, Lim, HD, Alamein, C, Manandhar, P, Santiago, M, Fritzwanker, S, Schmiedel, F, Katte, TA, Reekie, T, Grimsey, NL, Kassiou, M, Kellam, B, Krasel, C, Halls, ML, Connor, M, Lane, JR, Schulz, S, Christie, MJ, Canals, M

Volltext bestellen

Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists von Gillis, Alexander, Gondin, Arisbel B., Kliewer, Andrea, Sanchez, Julie, Lim, Herman D., Alamein, Claudia, Manandhar, Preeti, Santiago, Marina, Fritzwanker, Sebastian, Schmidel, Frank, Katte, Timothy A., Reekie, Tristan, Grimsey, Natasha L., Kassiou, Michael, Kellam, Barrie, Krasel, Cornelius, Halls, Michelle L., Connor, Mark, Lane, J. Robert, Schulz, Stefan, Christie, Macdonald J., Canals, Meritxell

Volltext

HA-MOP knockin mice express the canonical µ-opioid receptor but lack detectable splice variants von Fritzwanker, Sebastian, Moulédous, Lionel, Mollereau, Catherine, Froment, Carine, Burlet-Schiltz, Odile, Effah, Felix, Bailey, Alexis, Spetea, Mariana, Reinscheid, Rainer K., Schulz, Stefan, Kliewer, Andrea

Volltext